ArticleDiscover oncology2022

Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors.

Soojung Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.